Jiangzhong Pharmaceutical: Participation in the establishment of CR Pharmaceutical Industry Investment Fund Phase II.

Jiangzhong Pharmaceutical announced that the company plans to establish the CR Pharmaceutical (Chengdu) Innovation Investment Fund with 10 limited partners including CR Pharmaceutical Enterprise Management Partnership Enterprise. The fund has a size of 1 billion RMB. As a limited partner, the company will contribute 40 million RMB from its own funds, holding 4% of the fund's property share. This transaction constitutes a joint investment with related parties and professional investment institutions, and does not constitute a major asset restructuring.